Effects of a MAPK p38 inhibitor on lung function and airway inflammation in equine recurrent airway obstruction

Equine Veterinary Journal

Volumn 40, Issue 6, 2008, Pages 577-583

  Lavoie, J P ^a   Thompson, D ^b   Hamilton, E ^a   Debrue, M ^a   David, F ^a   Hickey, G ^b  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Bronchoalveolar lavage; Heaves; Horse; Lung function; Pulmonary inflammation; Rao; Recurrent airway obstruction

Indexed keywords

ANTIINFLAMMATORY AGENT; DEXAMETHASONE; MITOGEN ACTIVATED PROTEIN KINASE P38;

ANIMAL; ANIMAL DISEASE; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; FEMALE; HORSE; HORSE DISEASE; HOSPITALIZATION; INFLAMMATION; INTRAVENOUS DRUG ADMINISTRATION; LUNG; LUNG FUNCTION TEST; LUNG LAVAGE; MALE; PATHOLOGY; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; TREATMENT OUTCOME;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BRONCHOALVEOLAR LAVAGE FLUID; DEXAMETHASONE; FEMALE; HORSE DISEASES; HORSES; INFLAMMATION; INJECTIONS, INTRAVENOUS; LUNG; LUNG DISEASES, OBSTRUCTIVE; MALE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RECURRENCE; RESPIRATORY FUNCTION TESTS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EQUIDAE;

EID: 50949087902     PISSN: 04251644     EISSN: None     Source Type: Journal    
DOI: 10.2746/042516408X284646     Document Type: Article

References (28)

1. Ainsworth, D.M., Wagner, B., Franchini. M., Grunig, G., Erb, H.N. and Tan. J.Y. (2006) Time-dependent alterations in gene expression of interleukin-8 in the bronchial epithelium of horses with recurrent airway obstruction. Am. J. vet. Res. 67, 669-677.
2. Aoshiba, K., Yasui, S., Hayashi, M., Tamaoki, J. and Nagai, A. (1999) Role of p38-mitogen-activated protein kinase in spontaneous apoptosis of human neutrophils. J. Immunol. 162, 1692-1700.
3. Baskett, A., Barton, M.H., Norton, N., Anders, B. and Moore, J.N. (1997) Effect of pentoxifylline, flunixin meglumine, and their combination on a model of endotoxemia in horses. Am. J. vet. Res. 58, 1291-1299.
4. Brideau, C., Van Staden, C., Styhler, A., Rodger, I.W. and Chan, C.C. (1999) The effects of phosphodiesterase type 4 inhibitors on tumour necrosis factor-alpha and leukotriene B4 in a novel human whole blood assay. Br. J. Pharmacol. 126, 979-988.
5. Debrue, M., Hamilton, E., Joubert, P., Lajoie-Kadoch, S. and Lavoie, J.P. (2005) Chronic exacerbation of equine heaves is associated with an increased expression of interleukin-17 mRNA in bronchoalveolar lavage cells. Vet. Immunol. Immunopathol. 105, 25-31.
6. Dombroski, M.A., Letavic, M.A., McClure, K.F., Barberia, J.T., Carty, T.J., Cortina, S.R., Csiki, C., Dipesa, A.J., Elliott, N.C., Gabel, C.A., Jordan, C.K., Labasi, J.M., Martin, W.H., Peese, K.M., Stock, I.A., Svensson, L., Sweeney, F.J. and Yu, C.H. (2004) Benzimidazolone p38 inhibitors. Bioorg. Med. Chem. Lett. 14, 919-923.
7. Drost, E.M. and MacNee, W. (2002) Potential role of IL-8, platelet-activating factor and TNF-alpha in the sequestration of neutrophils in the lung: effects on neutrophil deformability, adhesion receptor expression, and chemotaxis. Eur. J. Immunol. 32, 393-403.
8. Gerthoffer, W.T. and Singer, C.A. (2003) MAPK regulation of gene expression in airway smooth muscle. Respir. Physiol. Neurobiol. 137, 237-250.
9. Haddad, E.B., Birrell, M., McCluskie, K., Ling, A., Webber, S.E., Foster, M.L. and Belvisi, M.G. (2001) Role of p38 MAP kinase in LPS-induced airway inflammation in the rat. Br. J. Pharmacol. 132, 1715-1724.
10. Hale, K.K., Trollinger, D., Rihanek, M. and Manthey, C.L. (1999) Differential expression and activation of p38 mitogen-activated protein kinase alpha, beta, gamma, and delta in inflammatory cell lineages. J. Immunol. 162, 4246-4252.
11. Hoffmann, E., Dittrich-Breiholz, O., Holtmann, H. and Kracht, M. (2002) Multiple control of interleukin-8 gene expression. J. Leukoc. Biol. 72, 847-855.
12. Jiang, Y., Gram, H., Zhao, M., New, L., Gu, J., Feng, L., Di Padova, F., Ulevitch, R.J. and Han, J. (1997) Characterization of the structure and function of the fourth member of p38 group mitogen-activated protein kinases, p38delta. J. hiol. Chem. 272, 30122-30128.
13. Kaminska, B. (2005) MAPK signalling pathways as molecular targets for antiinflammatory therapy - from molecular mechanisms to therapeutic benefits. Biochim. Biophys. Acta 1754, 253-262.
14. Kolm, G., Zappe, H., Schmid, R., Riedelberger, K. and Van den Hoven, R. (2003) Efficacy of montelukast in the treatment of chronic obstructive pulmonary disease in five horses. Vet. Rec. 152, 804-806.
15. Lavoie, J.P., Leguillette, R., Pasloske, K., Charette, L., Sawyer, N., Guay, D., Murphy, T. and Hickey, G.J. (2002) Comparison of effects of dexamethasone and the leukotriene D4 receptor antagonist L-708,738 on lung function and airway cytologic findings in horses with recurrent airway obstruction. Am. J. vet. Res. 63, 579-585.
16. Lavoie, J.P., Pasloske, K., Joubert, P., Cordeau, M.E., Mancini, J., Girard, Y., Friesen, R.W., Frenette, R., Blouin, M., Young, R.N. and Hickey, G. (2006) Lack of clinical efficacy of a phosphodiesterase-4 inhibitor for treatment of heaves in horses. J. vet. int. Med. 20, 175-181.
17. Leguillette, R., Désévaux, C. and Lavoie, J.P. (2002) Effects of pentoxifylline on pulmonary function and results of cytologic examination of bronchoalveolar lavage fluid in horses with recurrent airway obstruction. Am. J. vet. Res. 63, 459-463.
18. Liverton, N.J., Butcher, J.W., Claiborne, C.F., Claremon, D.A., Libby, B.E., Nguyen, K.T., Pitzenberger, S.M., Selnick, H.G., Smith, G.R., Tebben, A., Vacca, J.P., Varga, S.L., Agarwal, L., Dancheck, K., Forsyth, A.J., Fletcher, D.S., Frantz, B., Hanlon, W.A., Harper, C.F., Hofsess, S.J., Kostura, M., Lin, J., Luell, S., O'Neill, E.A., O'Keefe, S.J. et al. (1999) Design and synthesis of potent, selective, and orally bioavailable terrasubstituted imidazole inhibitors of p38 mitogen-activated protein kinase. J. med. Chem. 42, 2180-2190.
19. Newton, R. and Holden, N. (2003) Inhibitors of p38 mitogen-activated protein kinase: potential as anti-inflammatory agents in asthma? Bio. Drugs 17, 113-129.
20. Nick, J.A., Young, S.K., Brown, K.K., Avdi. N.J., Arndt, P.G., Suratt, B.T., Janes, M.S., Henson, P.M. and Worthen, G.S. (2000) Role of p38 mitogen-activated protein kinase in a murine model of pulmonary inflammation. J. Immunol. 164, 2151-2159.
21. Nick, J.A., Avdi, N.J., Young, S.K., Lehman, L.A., McDonald, P.P., Frasch, S.C., Billstrom, M.A., Henson, P.M., Johnson. G.L. and Worthen. G.S. (1999) Selective activation and functional significance of p38alpha mitogen-activated protein kinase in lipopolysaccharide-stimulated neutrophils. J. clin. Invest. 103, 851-858.
22. Nick, J.A., Young, S.K., Arndt, P.G., Lieber, J.G., Suratt, B.T., Poch, K.R., Avdi. N.J., Malcolm, K.C., Taube. C., Henson, P.M. and Worthen, G.S. (2002) Selective suppression of neutrophil accumulation in ongoing pulmonary inflammation by systemic inhibition of p38 mitogen-activated protein kinase. J. Immunol. 169, 5260-5269.
23. Prause, O., Laan, M., Lotvall, J. and Linden, A. (2003) Pharmacological modulation of interleukin-17-induced GCP-2-, GRO-alpha- and interleukin-8 release in human bronchial epithelial cells. Eur. J. Pharmacol. 462, 193-198.
24. Robinson, N.E., Olszewski, M.A., Boehler, D., Berney, C., Hakala, J., Matson, C. and Derksen, F.J. (2000) Relationship between clinical signs and lung function in horses with recurrent airway obstruction (heaves) during a bronchodilator trial. Equine vet. J. 32, 393-400.
25. Schnyder-Candrian, S., Quesniaux, V.F., Di Padova, F., Maillet, I., Noulin, N., Couillin, I., Moser, R., Erard, F., Vargaftig, B.B., Ryffel, B. and Schnyder, B. (2005) Dual effects of p38 MAPK on TNF-dependent bronchoconstriction and TNF-independent neutrophil recruitment in lipopolysaccharide-induced acute respiratory distress syndrome. J. Immunol. 175, 262-269.
26. Taube, C., Nick, J.A., Siegmund, B., Duez, C., Takeda, K., Rha, Y.H., Park, J.W., Joetham, A., Poch, K., Dakhama, A., Dinarello, C.A. and Gelfand, E.W. (2004) Inhibition of early airway neutrophilia does not affect development of airway hyperresponsiveness. Am. J. Respir. cell mol. Biol. 30, 837-843.
27. Underwood, D.C., Osborn, R.R., Bochnowicz, S., Webb, E.F., Rieman, D.J., Lee, J.C., Romanic, A.M., Adams, J.L., Hay, D.W. and Griswold, D.E. (2000) SB 239063, a p38 MAPK inhibitor, reduces neutrophilia, inflammatory cytokines, MMP-9, and fibrosis in lung. Am. J. Physiol. Lung cell mol. Physiol. 279, L895-902.
28. Wang, X.S., Diener, K., Manthey, C.L., Wang, S., Rosenzweig, B., Bray, J., Delaney, J., Cole, C.N., Chan-Hui, P.Y., Mantlo, N., Lichenstein, H.S., Zukowski, M. and Yao, Z. (1997) Molecular cloning and characterization of a novel p38 mitogen-activated protein kinase. J. hiol. Chem. 272, 23668-23674.